Saves the questions and what to expect into your notes, next to the visit they belong to.
Keep this study
Lead
Pak Emirates Military Hospital
Eligible patients will be assigned to one of two groups: Elagolix 150 mg once daily or OCPs daily, based on physician recommendation and patient preference. Baseline demographic and clinical information will be recorded. Pain outcomes (dysmenorrhea, dyspareunia, non menstrual pain) will be assessed on the NRS at baseline, 12 weeks, and 24 weeks. Adverse events will be documented throughout.
Age
18–45
Sex
FEMALE
Healthy volunteers
Not accepted
You may be eligible if
Women aged 18-45 years
clinically or surgically confirmed endometriosis
having regular menstrual cycles
willingness to participate with informed consent.
You may not be if
Contraindications to OCPs (e.g., thromboembolism, cardiovascular disease, uncontrolled hypertension, smoking over age 35)
Contraindications to Elagolix (e.g., osteoporosis, pregnancy, hypersensitivity, severe depression) Prior hysterectomy or bilateral oophorectomy, Other identifiable causes of pelvic pain.